pSivida to list on German exchanges

Jan. 16, 2004 — pSivida Limited, an Australian biotechnology company working to commercialize nanostructured porous silicon, announced that it will trade under the symbol PSI on the Berlin, Munich and Stuttgart stock exchanges. The company’s stock will continue trading on the Australian and Frankfurt exchanges.


The company’s managing director, Gavin Rezos, said in a prepared statement that the additional listings “will further increase the profile of pSivida with both institutional and retail investors in Germany and across Europe.”


pSivida recently signed a licensing agreement with a German research agency to use its technology in diagnostic applications.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.